Clinical significance of half-hepatic blood flow occlusion technology in patients with hepatocellular carcinoma with cirrhosis

Table 5 Comparison of inflammatory factors between the two groups of patients before and after surgery (mean ± SD)

Index	Research group (n = 44)	Control group (n = 44)	t value	P value
IL-6 (pg/mL)
Preoperative	54.23 ± 9.50	56.39 ± 9.11	-1.089	0.279
24 h after operation	97.41 ± 17.59	108.26 ± 18.25	-2.839	0.006
72 h after operation	70.55 ± 13.02	74.18 ± 14.40	-1.240	0.218
TNF-α (pg/mL)
Preoperative	68.33 ± 13.20	70.53 ± 12.65	-0.798	0.427
24 h after operation	148.12 ± 21.04	167.00 ± 24.28	-3.898	0.000
72 h after operation	98.40 ± 13.27	102.73 ± 15.19	-1.424	0.158
CRP (mg/L)
Preoperative	4.91 ± 1.53	5.34 ± 1.58	-1.297	0.198
24 h after operation	18.48 ± 3.75	20.14 ± 4.43	-1.897	0.061
72 h after operation	14.20 ± 3.36	15.38 ± 4.28	-1.438	0.154

IL-6: interleukin-6; TNF-α: tumor necrosis factor-α; CRP: C-reactive protein.